Relmada Therapeutics, Inc. (RLMD)
5.91
-0.24
(-3.90%)
USD |
NASDAQ |
Mar 13, 16:00
5.90
-0.01
(-0.17%)
After-Hours: 20:00
Relmada Therapeutics EPS Diluted (Quarterly) : -0.304 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 0.0054 |
| Invivyd, Inc. | -0.0393 |
| Arcellx, Inc. | -1.003 |
| AN2 Therapeutics, Inc. | -0.3089 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.09M |
| Total Expenses (Quarterly) | 10.09M |
| Enterprise Value | 419.52M |
| Earnings Yield | -30.41% |
| Normalized Earnings Yield | -30.38 |